5a13be122b
Co-Authored-By: Claude Opus 4.8 <noreply@anthropic.com>
3.6 KiB
3.6 KiB
type, title, description, jurisdiction, legislature, session, identifier, citation, classification, subjects, status, primary_sponsors, version_count, action_count, vote_count, first_action, last_action, source, source_identifier, source_url, source_hash, vintage, source_snapshot, retrieved_at, confidence, tags
| type | title | description | jurisdiction | legislature | session | identifier | citation | classification | subjects | status | primary_sponsors | version_count | action_count | vote_count | first_action | last_action | source | source_identifier | source_url | source_hash | vintage | source_snapshot | retrieved_at | confidence | tags | ||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Bill | Opioids - As enacted, adds Alvogen, Inc., Apotex Corp., and Zydus Pharmaceuticals (USA) Inc. to the list of companies that may be released by the attorney general for pending or future claims regarding opioids. - Amends TCA Title 20 and Title 33. | Opioids - As enacted, adds Alvogen, Inc., Apotex Corp., and Zydus Pharmaceuticals (USA) Inc. to the list of companies that may be released by the attorney general for pending or future claims regarding opioids. - Amends TCA Title 20 and Title 33. | us/states/tn | Tennessee General Assembly | 114 | SB 1495 | Tennessee SB 1495 (114) |
|
|
enacted |
|
1 | 18 | 3 | 2025-12-23 | 2026-05-18 | openstates | ocd-bill/f86a662d-a49a-48ff-ad8c-175ee63ef6ba | https://wapp.capitol.tn.gov/apps/BillInfo/Default?BillNumber=SB1495&ga=114 | 6ed1c0b8dd743a434ddc87580eb938e842e2af2a95475ca1ece1125bf87ebd7b | 2026-07-01 | https://data.openstates.org/daily/2026-07-01/public.pgdump | 2026-07-06 | reported |
|
Tennessee SB 1495 (114) — Opioids - As enacted, adds Alvogen, Inc., Apotex Corp., and Zydus Pharmaceuticals (USA) Inc. to the list of companies that may be released by the attorney general for pending or future claims regarding opioids. - Amends TCA Title 20 and Title 33.
Version chain
The bill's text revisions, in order — the diff chain from filing to enrollment.
- Current Version (committee substitute) — source
Votes
- FLOOR VOTE: Motion to Adopt 2/19/2026 Passed (1) — 31–0 (pass) · upper
- FLOOR VOTE: REGULAR CALENDAR PASSAGE ON THIRD CONSIDERATION 4/16/2026 Passed (1) — 87–0 (pass) · lower
- SENATE JUDICIARY COMMITTEE: Recommended for passage, refer to Senate Calendar Committee 2/10/2026 Passed — 8–0 (pass) · upper
Sponsors
- Haile — primary (person)
Timeline
The legislative action history — every referral, reading, and vote.
- 2025-12-23 Filed for introduction
filing - 2026-01-13 Introduced, Passed on First Consideration
introduction - 2026-01-14 Passed on Second Consideration, refer to Senate Judiciary Committee
referral-committee - 2026-02-03 Placed on Senate Judiciary Committee calendar for 2/10/2026
- 2026-02-10 Recommended for passage, refer to Senate Calendar Committee
- 2026-02-17 Placed on Senate Consent Calendar 2 for 2/19/2026
- 2026-02-19 Engrossed; ready for transmission to House
receipt - 2026-02-19 Passed Senate, Ayes 31, Nays 0
passage - 2026-02-23 Rcvd. from S., held on H. desk.
- 2026-04-16 Passed H., Ayes 87, Nays 0, PNV 1
passage - 2026-04-16 Subst. for comp. HB.
substitution - 2026-04-20 Enrolled and ready for signatures
enrolled - 2026-04-21 Signed by H. Speaker
passage - 2026-04-21 Signed by Senate Speaker
passage - 2026-04-23 Transmitted to Governor for action.
executive-receipt - 2026-05-05 Signed by Governor.
executive-signature - 2026-05-18 Effective date(s) 05/05/2026
- 2026-05-18 Pub. Ch. 888
Source
OpenStates / OpenCivicData bulk snapshot 2026-07-01; origin ocd-bill/f86a662d-a49a-48ff-ad8c-175ee63ef6ba. Confidence: reported (aggregated from official Tennessee legislature records).